Skip to main content
. 2013 Sep 20;8(9):e74886. doi: 10.1371/journal.pone.0074886

Figure 2. Rotarod test and PET-CT imaging.

Figure 2

Rotarod test (A) and PET-CT imaging (B) in the sham-, vehicle-, ASA-DA-pre-ischemia-groups. Only pretreatment with 20 mg/kg ASA-DA significantly ameliorates motor activity and impaired glucose metabolism (asterisks) (n = 7 per group; *P < 0.05, significantly different from the sham-group, #P < 0.05, significantly different from the vehicle-ischemia-group). The bars indicate the means ± SD.